| Product Code: ETC12942639 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand mRNA Therapeutics Contract Development Manufacturing Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand mRNA Therapeutics Contract Development Manufacturing Market - Industry Life Cycle |
3.4 Thailand mRNA Therapeutics Contract Development Manufacturing Market - Porter's Five Forces |
3.5 Thailand mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume Share, By Service Type, 2021 & 2031F |
3.6 Thailand mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Thailand mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Thailand mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Thailand mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 Thailand mRNA Therapeutics Contract Development Manufacturing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diseases that can be targeted by mRNA therapeutics in Thailand |
4.2.2 Growth in investments and collaborations in the mRNA therapeutics sector in Thailand |
4.2.3 Favorable government regulations and initiatives supporting the development of mRNA therapeutics in Thailand |
4.3 Market Restraints |
4.3.1 High upfront costs associated with setting up mRNA manufacturing facilities |
4.3.2 Lack of skilled workforce specialized in mRNA therapeutics manufacturing in Thailand |
4.3.3 Regulatory challenges and uncertainties in the approval process for mRNA therapeutics in Thailand |
5 Thailand mRNA Therapeutics Contract Development Manufacturing Market Trends |
6 Thailand mRNA Therapeutics Contract Development Manufacturing Market, By Types |
6.1 Thailand mRNA Therapeutics Contract Development Manufacturing Market, By Service Type |
6.1.1 Overview and Analysis |
6.1.2 Thailand mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Service Type, 2021 - 2031F |
6.1.3 Thailand mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Process Development, 2021 - 2031F |
6.1.4 Thailand mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Analytical Testing, 2021 - 2031F |
6.1.5 Thailand mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Manufacturing, 2021 - 2031F |
6.1.6 Thailand mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Formulation Development, 2021 - 2031F |
6.1.7 Thailand mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Regulatory Support, 2021 - 2031F |
6.2 Thailand mRNA Therapeutics Contract Development Manufacturing Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Thailand mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By mRNA Vaccines, 2021 - 2031F |
6.2.3 Thailand mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By mRNA Therapeutics, 2021 - 2031F |
6.2.4 Thailand mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By mRNA Drug Delivery, 2021 - 2031F |
6.2.5 Thailand mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Personalized Medicine, 2021 - 2031F |
6.2.6 Thailand mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Protein Replacement Therapy, 2021 - 2031F |
6.3 Thailand mRNA Therapeutics Contract Development Manufacturing Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Thailand mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Infectious Diseases, 2021 - 2031F |
6.3.3 Thailand mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Cancer Treatment, 2021 - 2031F |
6.3.4 Thailand mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Rare Diseases, 2021 - 2031F |
6.3.5 Thailand mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Genetic Disorders, 2021 - 2031F |
6.3.6 Thailand mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Autoimmune Diseases, 2021 - 2031F |
6.4 Thailand mRNA Therapeutics Contract Development Manufacturing Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Thailand mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.4.3 Thailand mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Biotechnology Firms, 2021 - 2031F |
6.4.4 Thailand mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Contract Manufacturing Organizations, 2021 - 2031F |
6.4.5 Thailand mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4.6 Thailand mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Clinical Research Organizations, 2021 - 2031F |
6.5 Thailand mRNA Therapeutics Contract Development Manufacturing Market, By Technology |
6.5.1 Overview and Analysis |
6.5.2 Thailand mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Lipid Nanoparticles, 2021 - 2031F |
6.5.3 Thailand mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By In Vitro Transcription, 2021 - 2031F |
6.5.4 Thailand mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Encapsulation Methods, 2021 - 2031F |
6.5.5 Thailand mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By CRISPR Technology, 2021 - 2031F |
6.5.6 Thailand mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By AI-Based Quality Control, 2021 - 2031F |
7 Thailand mRNA Therapeutics Contract Development Manufacturing Market Import-Export Trade Statistics |
7.1 Thailand mRNA Therapeutics Contract Development Manufacturing Market Export to Major Countries |
7.2 Thailand mRNA Therapeutics Contract Development Manufacturing Market Imports from Major Countries |
8 Thailand mRNA Therapeutics Contract Development Manufacturing Market Key Performance Indicators |
8.1 Percentage increase in the number of mRNA therapeutics research and development projects in Thailand |
8.2 Growth in the number of mRNA therapeutics manufacturing facilities established in Thailand |
8.3 Increase in the adoption of mRNA therapeutics in clinical trials in Thailand |
9 Thailand mRNA Therapeutics Contract Development Manufacturing Market - Opportunity Assessment |
9.1 Thailand mRNA Therapeutics Contract Development Manufacturing Market Opportunity Assessment, By Service Type, 2021 & 2031F |
9.2 Thailand mRNA Therapeutics Contract Development Manufacturing Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Thailand mRNA Therapeutics Contract Development Manufacturing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Thailand mRNA Therapeutics Contract Development Manufacturing Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Thailand mRNA Therapeutics Contract Development Manufacturing Market Opportunity Assessment, By Technology, 2021 & 2031F |
10 Thailand mRNA Therapeutics Contract Development Manufacturing Market - Competitive Landscape |
10.1 Thailand mRNA Therapeutics Contract Development Manufacturing Market Revenue Share, By Companies, 2024 |
10.2 Thailand mRNA Therapeutics Contract Development Manufacturing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here